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myocardial diffuse fibrosis assessment were established 
with incremental inclusion of imaging by averaging of the 
basal and mid-myocardial left ventricular levels, and each 
model was assessed for precision and correlation with col-
lagen volume fraction.
Results A model using 11 heart beat MOLLI imaging of 
two basal and two mid ventricular level averaged T1 maps 
provided improved precision (Intraclass correlation 0.93 vs 
0.84) and correlation with histology (R2 = 0.83 vs 0.36) for 
diffuse fibrosis compared to a single mid-ventricular level 
alone. ECV was more precise and correlated better than 
native T1 mapping.
Conclusion T1 mapping sequences with repeated averag-
ing could be considered for applications of 11 heartbeat 
MOLLI, especially when small changes in native T1/ECV 
might affect clinical management.
Keywords T1 mapping · MOLLI · Correlation with 
collagen volume fraction · Precision · Extracellular 
volume · Gadolinium
Introduction
The longitudinal relaxation time, T1, of the myocardium 
is regarded as a useful imaging biomarker, as it can 
change with cardiac pathology and is known to be associ-
ated with functional capacity and mortality [1–5]. Tradi-
tionally, late gadolinium enhancement (LGE) cardiovas-
cular magnetic resonance (CMR) exploits changes in T1 
following administration of a gadolinium–based contrast 
agent (Gd): namely, shortening of T1, which manifests as 
bright signal intensity on conventional inversion-recov-
ery gradient echo sequences. This has been used as the 
primary tool for identification of focal (or replacement) 
Abstract 
Objectives Our objectives involved identifying whether 
repeated averaging in basal and mid left ventricular myo-
cardial levels improves precision and correlation with col-
lagen volume fraction for 11 heartbeat MOLLI T1 mapping 
versus assessment at a single ventricular level.
Materials and methods For assessment of T1 mapping 
precision, a cohort of 15 healthy volunteers underwent 
two CMR scans on separate days using an 11 heartbeat 
MOLLI with a 5(3)3 beat scheme to measure native T1 and 
a 4(1)3(1)2 beat post-contrast scheme to measure post-
contrast T1, allowing calculation of partition coefficient 
and ECV. To assess correlation of T1 mapping with colla-
gen volume fraction, a separate cohort of ten aortic steno-
sis patients scheduled to undergo surgery underwent one 
CMR scan with this 11 heartbeat MOLLI scheme, followed 
by intraoperative tru-cut myocardial biopsy. Six models of 
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fibrosis, indicative of scar, and has entered clinical rou-
tine for multiple pathologies, including myocardial 
infarction and viability [6], cardiomyopathy [2, 7], con-
genital heart disease [8] and valvular heart disease [5, 9].
A limitation of T1-weighted inversion recovery 
sequences is that they rely on the nulling of signal in 
normal myocardium to highlight concentrations of Gd 
in fibrotic areas. In cases of diffuse (interstitial) fibro-
sis, however, where the myocardium can be globally 
affected, the myocardial signal may appear isointense 
and, hence, lack sensitivity in identifying fibrosis [10]. 
To address this unmet clinical need and allow identifica-
tion of diffuse myocardial fibrosis, new T1 mapping CMR 
sequences have been developed, based on the Modified 
Look-Locker inversion recovery (MOLLI) sequence 
first described by Messroghli and colleagues [11]. These 
allow imaging of extracellular volume fractions as a sur-
rogate for diffuse fibrosis [12–16].
Recent iterations of the MOLLI T1 mapping sequence 
acquire a total of 8 or 9 T1-weighted images over 11 heart 
beats [14, 17], in a 5b(3b)3b scheme pre-contrast, and a 
4b(1b)3b(1b)2b scheme post-contrast, where ‘b’ denotes 
beats and the values in brackets indicate pause inter-
vals. These shortened acquisitions enable rapid breath-
held imaging in around 8–12 s, depending on heart-
rate, compared to the 15–20 s required by older MOLLI 
sequences, which typically acquired T1-weighted images 
in a 3b(3b)3b(3b)5b scheme [11, 18]. While reducing the 
number of T1-weighted MOLLI source images from 11 
to 8/9 may reduce T1 precision, it also has the distinct 
advantage of increased reliability through better patient 
breath-holding. Therefore, the newer, faster sequences 
have enabled extended applications in patients with 
poorer breath-holding ability. However, before a new 
sequence is fit for clinical application, assessment of pre-
cision and accuracy is required, benchmarked against the 
reference standard of histologically derived quantifica-
tion of diffuse fibrosis.
We examined an 11 heartbeat (11HB) MOLLI proto-
type, by Siemens, with native 5b(3b)3b and post-contrast 
4b(1b)3b(1b)2b, which is referred to in the main text as 
MOLLI for brevity. This sequence has undergone little 
exploratory validation, and thus the aim of this work is to:
(1) explore the effect of six imaging models (models A–F, 
Table 1) on precision and correlation with collagen 
volume fraction (CVF), which we use as a surrogate 
for accuracy; these models use incremental averaging 
of left ventricular slices (up to two averages at basal 
and up to two at mid-ventricular levels, before and 
after Gd) here referred to as “incremental inclusion of 
images”, and will be compared with the conventional 
use of only one mid-ventricular level slice;
(2) histologically validate the 5b(3b)3b and 
4b(1b)3b(1b)2b 11 heart beat MOLLI prototype in 
patients who have left ventricular myocardial biopsy at 
the time of aortic valve surgery; and
(3) explore the relative precision and correlation with CVF 
of native T1 mapping, partition coefficient, and extra-
cellular volume fraction (ECV).
Materials and methods
Population cohorts
Two cohorts of participants were recruited for this work: a 
group of healthy volunteers for estimating T1 mapping pre-
cision, and a group of aortic stenosis patients for estimat-
ing T1 mapping correlation with CVF. Written consent was 
obtained from all patients and volunteers, and the study 
was conducted after local research ethics approval from the 
Royal Brompton and Harefield NHS Foundation trust and 
in accordance with the Declaration of Helsinki principles 
for Medical Research.
Cohort for estimating reproducibility/precision
Healthy volunteers taking no medication and with no 
known medical conditions were recruited following adver-
tisements on public notice boards. The volunteers under-
went a detailed health questionnaire and blood screening 
to measure haemoglobin, renal function, liver function, 
thyroid function, and C-reactive protein. The bloods were 
measured in a clinical biochemistry laboratory. Addi-
tionally, blood pressure, heart rate, and temperature were 
recorded. All volunteers underwent electrocardiography. 
In the event that an abnormality (e.g., hypertension, ECG 
abnormalities, renal failure) was detected that could have 
affected the results, the participant was excluded.
Table 1  Using the four native and four post-Gd images it was pos-
sible to construct a total of 6 T1 mapping models
The “x” marks the slice location of inclusion of the additional imag-
ing
Basal level Repeated Mid-level Repeated
Model A x
Model B x
Model C x x
Model D x x
Model E x x
Model F x x x x
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Cohort for estimating correlation with collagen volume 
fraction
A cohort of patients with severe aortic stenosis, scheduled 
for surgical aortic valve replacement, was recruited from 
outpatient clinics or inpatient wards at the Royal Bromp-
ton Hospital, London, UK. The patients were excluded 
if they had any contraindications to CMR or if they were 
scheduled for surgery for more than one valve. Patients 
who were scheduled for concurrent aortic valve replace-
ment and coronary artery by-pass grafting (CABG) were 
included. As this was a correlation study, the patients were 
not excluded if they had treated hypertension, hyperlipidae-
mia, or diabetes.
Assuming similar correlations to histological CVF to 
previous published data [12], we estimated that a minimum 
of five patients would be required to detect an R2 correla-
tion of at least 0.8 with 80% power. We opted to double 
this number to ten patients, giving us 90% power to detect a 
statistically significant correlation assuming that the true R2 
correlation was at least 0.6.
Cardiovascular magnetic resonance
All CMR imaging was performed on a 1.5 T scanner (Sie-
mens Avanto, Erlangen, Germany). The quadrature body 
coil was used for radiofrequency transmission with 12–18 
elements of an anterior and posterior cardiac parallel array 
coil for reception. The standard manufacturer wireless-
ECG was used as in routine clinical work.
T1 mapping acquisition
The T1 mapping acquisition protocol was the same for both 
volunteers and aortic stenosis patients. Following adjust-
ment of the scanner reference frequency to the predominant 
Larmor nuclear magnetic resonance precession frequency 
of the signal received from a cuboid volume region over the 
left-heart (“volume adjust”, ideally performed end-expira-
tion), MOLLI T1 mapping was applied with the following 
parameters: Single-shot balanced steady-state free-preces-
sion images, field-of-view = 360 × 306 mm, slice thick-
ness = 8 mm, alpha pulse flip angle = 35o, 7/8ths partial ky 
acquisition with 1/8th zero-filling, a generalised autocali-
brating partially parallel acquisition acceleration factor of 
2 with 24 central ky lines fully acquired to obtain receiver 
coil profiles, and 1085 Hz/pixel ADC sampling bandwidth. 
The T1 weighting was initially TI = 120 ms, incrementing 
by 80 ms at the start of each Look-Locker set. Two differ-
ent MOLLI acquisitions were used depending on partici-
pant heart rates: a high-resolution acquisition for heart rates 
less than 90 bpm and a low-resolution acquisition for heart 
rates greater than 90 bpm. Two different sequences were 
required because the high-resolution acquisitions were too 
long to fit into the stationary diastole phase for faster heart 
rates. The following parameters varied between high-reso-
lution and low-resolution setups, and these differences have 
been shown to have negligible impact on T1 values while 
maximising image quality [10].
High resolution: TR/TE = 2.6/1.12 ms, 84 acquired PE 
lines, single-shot image duration 220 ms, Acquired pixel 
size 1.4 mm (FE) × 2.1 mm (PE).
Low resolution: TR/TE = 2.4/1.0 ms, 76 acquired PE 
lines, single-shot image duration 182 ms, Acquired pixel 
size 1.9 mm (FE) × 2.4 mm (PE).
Further, for the low- and high-resolution MOLLI acqui-
sitions, two different MOLLI sampling schemes were used 
pre- and post-contrast [10]: a 5b(3b)3b scheme was used 
for native T1 values and a 4b(1b)3b(1b)2b scheme was used 
for post-contrast T1.
A total of four native T1 maps were acquired (one basal 
and repeated once; one mid-ventricular level and repeated 
once). Then, starting fifteen minutes after Gd administra-
tion, post-Gd MOLLI T1 maps were acquired at basal and 
mid-ventricular levels (and repeated once at each level, giv-
ing rise to four post-Gd T1 maps) using the 4b(1b)3b(1b)2b 
scheme, again with low or high resolution depending on the 
heart rate. In total, four native T1 maps and four post-con-
trast T1 maps were obtained. The addition of a complete T1 
mapping protocol to a clinical scan increased the total scan 
time by about 5–7 min per patient.
To assess interscan reproducibility, the healthy volun-
teers underwent a second CMR scan within 60 days of the 
first. To mimic routine clinical practice, the staff undertak-
ing the second scan were unaware of the exact slice posi-
tion used for acquisition in the first scan. The aortic steno-
sis patients underwent a single CMR scan as close to the 
day of surgery as possible.
Image post‑processing and analysis
For quantification of LV function, volumes, and T1 values, 
dedicated software CMR Tools (Cardiovascular Imaging 
Solutions, London, UK, Fig. 1) was used by experienced 
(level 3 SCMR) blinded operators. Visual inspection of the 
colour maps was undertaken both in-line on the Siemens 
platform and off-line using CMR 42 (Circle CVI, Calgary, 
Canada, Fig. 2).
MOLLI T1 maps were generated automatically in-line 
on the scanner workstation, following motion correc-
tion and pixel-by-pixel curve fitting with Look-Locker 
correction. DICOM images were anonymised and maps 
were analysed in a blinded fashion by two observers 
to evaluate interstudy and interobserver variability. A 
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third observer adjudicated values of >5% relative differ-
ence. Native and post-Gd MOLLI source images were 
inspected and a quality score from 1 to 5, with five being 
excellent and 1 very poor, was recorded for respiratory 
drift, cardiac motion artefact, and appropriate cardiac 
triggering of each image, before proceeding with meas-
urements on the derived T1-maps. Only patients scoring 
≥4 in all categories were subsequently included in the 
analysis.
Regions of interest (ROIs) were drawn on the T1 maps 
(Fig. 1) within the mid-wall of the septum, with care 
being taken to avoid partial-volume or cardiac-motion-
related blurring of the myocardium-blood boundary, 
where blood signal contaminates myocardial data. A sec-
ond set of ROIs were drawn in the blood, avoiding myo-
cardium and papillary muscles. A standardised approach 
was undertaken in all patients with regards to the location 
of the ROI, and all areas were included, even if they were 
subsequently shown to have LGE. This had been decided 
a priori, as in patients where only native T1 mapping is 
undertaken, one does not have the subsequent benefit of 
knowing where LGE is present, and therefore our proto-
col was standardised in this way for all the patients.
Once native and post-Gd myocardial and blood val-
ues and haematocrit were obtained, extracellular volumes 
(ECVs) were calculated as shown in Eq. (1):
where T1 myopost and T1 myopre are the T1 values of post-
contrast and native myocardium, and T1 bloodpost and 
T1 bloodpre are the T1 values of post-contrast and native 
blood, respectively.
Myocardial biopsy: procedure and analysis
All aortic stenosis patients included underwent success-
ful myocardial biopsy intraoperatively using the follow-
ing standardised protocol: Once the chest was opened 
and cardiopulmonary bypass was established, a long 
near-transmural left ventricular “tru-cut” biopsy was 
taken. The aim was to undertake multiple biopsies pro-
vided that patient safety was not compromised. Upon 
completion of the biopsy, the myocardium was sutured, 
(1)ECV = (1− haematocrit) ∗
(
1
T1myopost
−
1
T1myopre
)
(
1
T1bloodpost
−
1
T1bloodpre
)
Fig. 1  Representative short axis images from a healthy volunteer 
with native T1 maps (a–d) and post gad T1 maps (e–h). One basal and 
one mid-ventricular level were selected and imaging at each level was 
repeated both before and after the administration of Gd (a, b native 
T1 basal; e, f post-Gd basal; c, d native T1 mid-ventricular level, g, h, 
mid-ventricular level post-Gd). Regions of interest (ROI) were drawn 
in the myocardium and blood
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if required, and surgery continued as normal. The myo-
cardial biopsies were immediately fixed in warm buff-
ered 4% formalin. Histological analysis of fibrosis was 
undertaken on 3-µm-thick sections from formalin-fixed, 
paraffin-embedded endomyocardial biopsies using a spe-
cial collagen stain (Picrosirius red). Quantification was 
performed using standardised semiautomatic image anal-
ysis software (Nikon Advanced Research NIS Elements 
imaging software, NIS elements AR 4.10.02, Nikon) on 
images of 14 randomly chosen consecutive high-power 
fields (×200 magnification), which were obtained with a 
Nikon Eclipse E400 light projection microscope (Nikon, 
Minato, Tokyo, Japan). The 14 high power fields equaled 
1 mm2. Endocardium, subendocardial fibrosis and suben-
docardial fat, procedure-related optically empty spaces 
and epicardial fat were eliminated from analysis. Sub-
sequent image analysis was performed to determine the 
level of fibrosis including reactive, band-like perimysial 
collagen depositions and perivascular fibrosis, defined as 
collagen surrounding arterioles. Fibrosis was calculated 
as the collagen volume fraction (%) per square millim-
eter, as previously described [19].
Statistical analysis
The CMR native T1 values, partition coefficients, and 
ECVs were compared to the histologically identified col-
lagen volume fraction (CVF). Intraclass correlation coeffi-
cients (ICC) were calculated using ‘R’ (R Foundation for 
Statistical Computing, Vienna, Austria) and used to assess 
agreement in the healthy volunteer ‘precision’ cohort. For 
the aortic stenosis ‘correlation with CVF’ cohort, graph-
plotting and analysis was again undertaken using the statis-
tics package ‘R’. The six models, A–F, described for CMR 
estimation of myocardial diffuse fibrosis were compared to 
identify the most reproducible model (from the volunteer 
precision cohort) and most accurate/correlating with CVF 
(from the aortic stenosis biopsy cohort). There is no pub-
lished method of incorporating both precision and accuracy 
(via correlation with CVF) in one single measurement for 
such imaging work. We therefore proposed and calculated 
the product of the scan-rescan R2 values for the volunteer 
(precision) and ECV-histological fibrosis R2 for aortic ste-
nosis biopsy patients (correlation with CVF) as a single 
combined measure of correlation with CVF and precision 
Fig. 2  a showing a basal slice 
with native T1 mapping using 
the high resolution 5(3)3 beat 
sequence as the heart rate was 
58 bpm. b shows the post-Gd 
image using a high resolution 
4(1)3(1)2 beat sequence. c 
shows the native T1 mapping 
and d the post-Gd contrast T1 
mapping using the same high 
resolution sequence as in (a, 
b) respectively, but at the mid-
ventricular level
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for this imaging modality, described in this manuscript as 
Product of R2.
Results
Reproducibility‑precision: the volunteer cohort
Fifteen healthy volunteers, eight males, mean 
age = 31 ± 5 years, were recruited and the reproducibility of 
their corresponding native T1 maps, post Gd T1 maps, parti-
tion coefficient and ECV results are shown in Table 2. All vol-
unteers had an HR < 90 bpm for both scans, and; therefore, 
the higher resolution sequence was used. Participants toler-
ated both scans well with no complications and excellent T1 
mapping images were obtained. No volunteer was excluded 
due to respiratory drift, cardiac motion artefact, or inappro-
priate cardiac triggering. There was no statistically significant 
difference between the two scans with regards to heart rate, 
blood pressure, or haematocrit (p = 0.27, p = 0.19, p = 0.89, 
respectively). Both interstudy T1 and interstudy ECV dif-
ferences showed excellent results (Bland–Altman shown in 
Fig. 3 for native T1 and Fig. 4 for ECV, respectively).  
Both intra- and interobserver variability were excellent. 
Intraobserver ICCs were: 0.995 for native T1 (p < 0.001), 
0.996 for partition coefficient (p < 0.001) and 0.999 for 
Table 2  Showing interscan 
reproducibility
The six models A–F incorporating increasing levels and averaging of myocardial T1 maps are shown. 
Model C–F showed the best extracellular volume (ECV) reproducibility
ICC intraclass correlation
Interstudy reproducibility
Basal Repeat Mid Repeat Native T1
mapping
Post Gd mapping Partition coefficient ECV
ICC
p value
ICC
p value
ICC
p value
ICC
p value
Model A x 0.90
P < 0.001
0.72
p = 0.014
0.53
p = 0.098
0.84
p = 0.001
Model B x 0.84
p = 0.001
0.68
p = 0.018
0.4
p = 0.17
0.75
p = 0.006
Model C x x 0.88
p < 0.001
0.82
p = 0.002
0.81
p = 0.002
0.94
p < 0.001
Model D x x 0.80
p = 0.001
0.75
p = 0.006
0.66
p = 0.024
0.88
p < 0.001
Model E x x 0.90
p < 0.001
0.71
p = 0.013
0.54
p = 0.08
0.88
p < 0.001
Model F x x x x 0.88
p < 0.001
0.79
p = 0.003
0.81
p = 0.002
0.93
P < 0.001
Fig. 3  Bland–Altman analysis of T1, including mean difference, correlation, and distribution of differences plots. Mean difference = 11.5 ms 
(red line on difference plot) with limits of agreement at −21 and 43 ms; the line of zero difference (dashed) is within the limits of agreement
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ECV (p < 0.001). Interobserver ICCs were: 0.993 for native 
T1 (p < 0.001), 0.985 for partition coefficient (p < 0.001), 
and 0.997 for ECV (p < 0.001).
Correlation with collagen volume fraction: The aortic 
stenosis cohort
Ten consecutive patients with symptomatic severe aor-
tic stenosis scheduled for surgical valve replacement 
underwent CMR and intraoperative myocardial biop-
sies: eight male, mean age = 71 ± 10 years, and three 
with significant major epicardial coronary artery disease 
(defined as disease >50% of lumen diameter) requiring 
CABG at the time of the operation. Of these patients, 
five received treatment for hypertension and their blood 
pressure was well controlled at the time of the CMR 
(BP < 140/90 mmHg), four had treated hyperlipidaemia, 
two had chronic obstructive pulmonary disease requir-
ing bronchodilators and two had prior distant history of 
neoplasia (breast/bladder). Of the three patients requiring 
CABG, one had 2-vessel CABG (left anterior descending 
(LAD) and circumflex) and the other two had single ves-
sel CABG (one of the LAD and one of the intermediate 
coronary artery respectively). No patients suffered from 
diabetes. All patients tolerated the CMR well and the T1 
mapping images were free from disqualifying artefacts 
and were diagnostic in all participants. In one patient the 
initial native T1 maps needed repeating in view of poor 
breathholding. This was appreciated during the scan, and 
therefore was repeated before proceeding to Gd adminis-
tration. The repeat maps were of acceptable quality with 
no apparent respiratory drift, cardiac motion artefact, or 
inappropriate cardiac triggering. All patients had api-
cal–lateral wall biopsies taken intraoperatively and no 
patients had biopsies from all three basal, mid, and apical 
levels due to surgical concerns. One patient had to be 
taken back to theatre within 24 h from surgery for bleed-
ing, which may have been related to the apical myocar-
dial biopsy sampling. The patient made a good recovery 
and discharged home within five days with no further 
sequela. No other side-effects relating to the myocardial 
biopsies were seen. Therefore, the basal and/or mid-myo-
cardial T1 values were taken as a surrogate for a global T1 
value and were correlated with histology from the apical–
lateral wall. Microscopic views of the sections prepared 
from the biopsies are shown in Fig. 5.
The relative correlation with CVF of native T1 maps, 
partition coefficient, and ECV were assessed using histol-
ogy. The histologically derived CVF was plotted against 
each of these parameters, as shown in Table 3. Native T1 
values from model F (which had shown best correlation) 
showed a moderate, statistically-significant correlation with 
the histologically obtained fibrosis burden, with R2 = 0.42, 
and p = 0.046. However, the partition coefficient and 
ECV both showed strong correlations with histology, with 
R2 = 0.81 and R2 = 0.83, and these both were statistically 
significant, with p < 0.001 (Table 3; Fig. 6). 
Having established that ECV was the most accurate 
imaging parameter from T1 mapping, we further inves-
tigated the incremental addition of more myocardial 
regions and averaged slices. When only one mid-level T1-
map was used (i.e., Model A), the correlation with histol-
ogy was only modest, and was not significant (R2 = 0.36, 
p = 0.068), similar to data from published studies that used 
only one mid-level T1-map [14, 20]. Increasing the num-
ber of T1 maps, and including the basal level as well as the 
mid-ventricular-level in this averaging improved the corre-
lation significantly: R2 = 0.72, p = 0.002 when the aver-
age of a single basal and single mid-level image was used 
for ECV (Model E) and importantly R2 = 0.83, p < 0.001 
Fig. 4  Bland–Altman analysis of ECV, including mean difference, correlation, and distribution of differences plots. Mean difference = 0.003 
(red line on difference plot) with limits of agreement at −0.024 and 0.029; the line of zero difference (dashed) is within the limits of agreement
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when acquisition was repeated at both basal and mid-levels 
(Model F) as shown in Table 3 and Fig. 7.
Combining precision and correlation with collagen 
volume fraction
To allow us to clarify the relative incremental addition 
of imaging for each model combining both accuracy (via 
correlation with CVF) and precision we sought a single 
parameter for each model to incorporate both correlation 
with CVF and precision. However, such a single meas-
ure has not been described for T1 mapping. We therefore 
devised a new model, incorporating the product of the R2 
from the precision cohort and R2 from the ‘correlation with 
CVF’ cohort as a unique parameter for each model. The 
results are shown in Table 4, and indicate that the inclusion 
of a repeated basal image and a repeated mid-image, giving 
a total of four native and four post Gd T1 maps to calculate 
ECV, was the most precise method with the best correlation 
with CVF.
Discussion
Any new CMR sequence needs to show both good accu-
racy and precision to become clinically relevant. In this 
work, we used two cohorts to establish precision and 
correlation with CVF (as a surrogate for accuracy) for 
an as yet non-validated T1 mapping sequence. Further-
more, this is the first time a study has reported a model 
of incremental image acquisition and averaging of basal 
and mid-ventricular T1-measurements as a means of 
obtaining an average of the global T1-mapping ECV. The 
volunteer cohort demonstrated that four models of slice 
Fig. 5  Samples from the intraoperative myocardial biopsies stained 
with Picrosirius red. a Shows fibrous septae, which show perivascu-
lar collagen to support mural arteries. There is no scarring, but only 
a slight increase in collagen fibres surrounding each cardiomyocyte 
(light red). b Shows interstitial fibrosis only, each cardiomyocyte 
is supported by a thin collagen layer (light red), there is only focal 
perivascular(pericapillary–capillary encircled) increase in collagen 
fibers (dark red area annotated). c Shows an annotated red area, quali-
fying as scar, as the dimension of the area exceeds double the diam-
eter of the adjacent hypertrophic cardiomyocyte indicated with ⟷
Table 3  showing the correlation of extracellular volume (ECV) by each model with histological collagen volume fraction (CVF) from apical–
lateral histology
It can be argued that in view of other myocardial pathologies co-existing with aortic stenosis such as oedema or ischaemia, CVF might not be 
the gold standard for fibrosis comparison. Therefore, this table should be interpreted in the appropriate clinical context. In patients with aortic 
stenosis, it would appear that ECV derived from the basal slice correlated better with CVF than the mid-ventricular level, but a combination of 
both the basal and mid had the best correlation. These results would suggest that further research is warranted to show whether imaging of basal 
and mid-ventricular level should be routinely undertaken in patients with aortic stenosis
Correlation of ECV with histological fibrosis
Basal level Basal repeated Mid-level Mid-level repeated ECV (%) R2 with histology p value
Model A x 27.47 0.36 0.068
Model B x 26.67 0.77 0.001
Model C x x 26.86 0.49 0.025
Model D x x 26.79 0.81 <0.001
Model E x x 27.07 0.72 0.002
Model F x x x x 26.83 0.83 <0.001
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acquisition and averaging showed an excellent interscan 
correlation. Model A native T1 mapping (one native T1 
mid-ventricular level slice), Model E native T1 mapping 
(average of one basal and one mid-level slice native T1), 
Model C ECV (average of ECV of two mid-level slices), 
and Model F ECV (average ECV of two basal and two 
mid-slices) all showed excellent interscan reproducibility, 
with R2 ≥ 0.90.
The correlation with CVF was assessed using a cohort 
of ten patients with aortic stenosis scheduled for surgical 
valve replacement who had CMR using our model of incre-
mental addition of imaging acquisitions and intraoperative 
biopsies. This confirmed that in aortic stenosis patients, 
measuring ECV in the mid-ventricular wall alone (Model 
A) showed only a trend towards weak correlation with 
histological collagen volume fraction (CVF), R2 = 0.36, 
p = 0.068. A model utilising the basal level alone (Model 
B) showed good correlation with histology (R2 = 0.77, 
p = 0.001), while a model based on one basal level being 
imaged twice and averaged (Model D) showed better cor-
relation (R2 = 0.81, p < 0.001). The best correlation was 
achieved by a model having one basal and one mid-ventric-
ular slice being imaged twice each and averaged (Model 
F, R2 = 0.83, p < 0.001). Incorporating both precision 
and correlation with CVF parameters into the Product R2, 
showed that ECV calculated from Model F was the most 
accurate and precise. We speculate that the improved corre-
lation and precision associated with Model F may relate to 
the incorporation of further areas of the myocardium (both 
basal and mid-ventricular level) and the repeat scan may 
serve to average out any potential errors associated with 
imaging a single slice.
This work therefore supports the following conclu-
sions: firstly, the 11 heart beat MOLLI prototype incorpo-
rating native 5b(3b)3b and post-contrast 4b(1b)3b(1b)2b 
schemes, was well tolerated by volunteers and patients. 
Secondly, when isolated native T1 mapping was used 
(without post-contrast T1 maps), it is reproducible in 
healthy volunteers, especially when Model A (one mid-
slice), Model C (one mid-slice repeated), Model E (one 
basal and one mid-slice), or Model F (one basal and one 
mid-ventricular level, both repeated) are used. Repeat-
ing native T1 maps does not appear to offer additional 
improvement in precision, as Model A performed at least 
as well as Models C, E and F. Thirdly, both partition coef-
ficient and ECV have been shown to be more accurate 
than native T1 maps alone. Therefore, we propose that 
post-Gd imaging (with or without haematocrit sampling) 
should be routinely undertaken when looking for an esti-
mation of diffuse fibrosis in patients. Fourthly, a sin-
gle mid-ventricular ECV measurement appears to show 
poorer correlation with CVF in patients with aortic ste-
nosis (as shown by Model A). Providing additional image 
repeats, such as model C, E or F for example, appear to 
show improved correlation with CVF. Although our study 
is not without its limitations, particularly regarding the 
use of the CVF as the reference standard, further work 
could consider whether the additional improvement in 
correlation provided by models C, E, and F, for example, 
might be of clinical importance. Finally, the most accu-
rate and precise model is Model F, whereby imaging of 
one basal and one mid-ventricular level slice, with both 
being repeated once, is performed both in the native state 
and after Gd administration.
Fig. 6  The agreement comparing (apical) histological CVF against 
ECV (a), native T1 mapping (b), and partition coefficient (c). There 
was good agreement between CVF and all the imaging parameters; 
however, partition coefficient and ECV performed considerably better 
than native T1 mapping alone
 Magn Reson Mater Phy
1 3
Fig. 7  a Showing the correlation of (apical–lateral) histological col-
lagen volume fractions (CVF) with ECV calculated from CMR at a 
single mid-ventricular level, corresponding to Model A and showing 
only mild non-significant correlation. b Showing correlation of his-
tological fibrosis with a single basal level (Model B), showing that 
for this pathology the correlation increases and has now become sig-
nificant. c Showing correlation between the average of one mid-level 
and one basal level (Model E) with histology showing a significant 
correlation. d Represents Model F with two basal and two mid-
slices showing that this model demonstrated the strongest correlation 
(R2 = 0.83, p < 0.001). This work confirms that including incremen-
tally more levels imaged improves accuracy
Table 4  Combining accuracy 
and precision in a single 
measurement, the Product of R2 
indicating that Model F offers 
the best imaging protocol (basal 
and repeat, mid-ventricular level 
and repeat) for optimal accuracy 
and precision
ECV extracellular volume
Basal Repeat Mid Repeat Volunteer interscan R2 ECV vs histology R2 Product of R2
Model A x 0.759 0.356 0.27
Model B x 0.722 0.773 0.56
Model C x x 0.808 0.486 0.39
Model D x x 0.637 0.809 0.52
Model E x x 0.623 0.715 0.45
Model F x x x x 0.778 0.829 0.65
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We therefore recommend that this should be consid-
ered if there is available scanner time and the patients 
can tolerate it. However, increasing scanner time (even by 
5–7 min) might not be possible in many busy CMR units. 
As such, undertaking repeats of basal and mid-ventricular 
levels might not be an option. Nonetheless, even in busy 
units it should be possible to undertake repeat imaging of 
a single level, which will only add two breathholds to the 
scan time. Therefore, if a unit undertakes a mid-ventricu-
lar slice T1 mapping routinely in the native and post-con-
trast state, we recommend that imaging at the same level 
is repeated once. This will provide additional improve-
ment in the correlation-precision, but also safeguard 
against potential poor breathholding, poor coregistration, 
or motion correction in one of the two acquisitions. Such 
a practical compromise will only increase scanner time by 
about 30 s. It should be noted that this relation only holds 
true for the 11HB sequence we have tested, and other 
MOLLI sequences might not behave in a similar way.
This study has certain limitations. Firstly, our samples for 
both cohorts were small; however, this is in line with other 
recently published studies, which also use small (fewer 
than ten patients) datasets for histological validation [21, 
22]. Secondly, we used healthy volunteers for the interscan 
reproducibility, as this was practically easier to achieve. As 
aortic stenosis patients can be more breathless and might 
have difficulties with breathholding, it is possible that the 
reproducibility might not be as good as for healthy controls. 
However, recently published work [23, 24] has shown that 
reproducibility in aortic stenosis was excellent, and there-
fore, we would not have anticipated different results to our 
controls, as T1 mapping in our aortic stenosis patients was 
of very good quality. Furthermore, we elected not to include 
apical T1 mapping in any of our T1 mapping strategies, as 
this region is known to suffer increased partial-volume 
artefact at the endocardial and epicardial borders, which 
are not perpendicular to the image slice in the apical short-
axis region [25]. Moreover, we did not undertake intra-
study reproducibility which could have provided additional 
information. We felt that intrascan reproducibility for ECV 
would be difficult to interpret as by default the post-Gd T1 
maps would be taken at different times. In addition, our 
myocardial biopsies were taken from the apico-lateral wall. 
Nonetheless, earlier studies have shown that, unlike replace-
ment fibrosis, where there is a significant difference between 
basal and apical areas [26], interstitial fibrosis tends to fol-
low a more homogenous pattern [23, 27] in patients with 
aortic stenosis. Therefore, we feel that our results are valid 
for the apico-lateral wall biopsies to represent global diffuse 
fibrosis measurement in these patients. Finally, it is appreci-
ated that other pathological processes might affect T1/ECV 
in aortic stenosis including oedema [25] and ischaemia [28, 
29]; therefore, the correlation between T1/ECV and CVF 
should be regarded as an association rather than causative, 
as there could be multiple aetiologies that might increase T1/
ECV.
Conclusion
This work was the first to utilise T1 mapping strategies with 
increasingly inclusive additional imaging for averaging the 
septal ECV measurements, going from one slice imaged 
to a total of four images (one basal repeated and one mid 
repeated) to improve both the correlation with CVF and 
the precision of the T1-measurement (both before and after 
Gd), comparing histological CVF estimation of fibrosis 
to the T1-mapping outcomes of native T1 maps, partition 
coefficient and ECV. We have shown that the 11 heartbeat 
MOLLI sequence used in this research, native 5b(3b)3b 
with post-contrast 4b(1b)3b(1b)2b, was well-tolerated in 
both volunteers and patients with aortic stenosis. Further-
more, it was both accurate and precise, particularly as incre-
mental imaging of additional basal and mid-ventricular slice 
images are included. Finally, this work also confirms that 
partition coefficient and ECV can be accurately used to cor-
relate with histological CVF estimation of diffuse fibrosis.
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